{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:19:29Z","timestamp":1765700369366,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CLRPG8B0052","CMRPG8A0751"],"award-info":[{"award-number":["CLRPG8B0052","CMRPG8A0751"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jfma.2015.11.008","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T14:12:23Z","timestamp":1450793543000},"page":"278-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C"],"prefix":"10.1016","volume":"115","author":[{"given":"Chao-Hung","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Houng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-1021","authenticated-orcid":false,"given":"Chuan-Mo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2015.11.008_bib1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/hep.510280632","article-title":"Prognosis of chronic hepatitis C: results of a large, prospective cohort study","volume":"28","author":"Niederau","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.11.008_bib2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0168-8278(98)80339-5","article-title":"Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients","volume":"28","author":"Ikeda","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2015.11.008_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"issue":"1 Suppl.","key":"10.1016\/j.jfma.2015.11.008_bib4","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2015.11.008_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2015.11.008_bib6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection","volume":"361","author":"McHutchison","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2015.11.008_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jfma.2015.06.012","article-title":"Hepatitis C virus infection in Taiwan: past, present, and future","volume":"115","author":"Kao","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2015.11.008_bib8","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/ijc.25585","article-title":"Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy","volume":"128","author":"Hung","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jfma.2015.11.008_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jfma.2015.11.008_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jvh.12097","article-title":"Role of hepatitis C virus substitutions and interleukin-28B polymorphism on response to peginterferon plus ribavirin in a prospective study of response-guided therapy","volume":"20","author":"Liang","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jfma.2015.11.008_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1586\/eri.11.33","article-title":"Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications","volume":"9","author":"Hung","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jfma.2015.11.008_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2008.07.013","article-title":"Treatment predictors of a sustained virologic response in hepatitis B and C","volume":"49","author":"Kau","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2015.11.008_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2015.11.008_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni.1851","article-title":"Vitamin D controls T cell antigen receptor signaling and activation of human T cells","volume":"11","author":"von Essen","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jfma.2015.11.008_bib15","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/carcin\/bgp103","article-title":"Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk","volume":"30","author":"Raimondi","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jfma.2015.11.008_bib16","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.23489","article-title":"Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C","volume":"51","author":"Petta","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.11.008_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jvh.12146","article-title":"Effect of vitamin D supplementation on pegylated interferon\/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial","volume":"21","author":"Yokoyama","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jfma.2015.11.008_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3748\/wjg.v18.i8.800","article-title":"Vitamin D improves viral response in hepatitis C genotype 2-3 na\u00efve patients","volume":"18","author":"Nimer","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jfma.2015.11.008_bib19","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/jgh.12949","article-title":"A randomized study comparing vitamin D3 and 1\u03b1 (OH) D3 in combination with pegylated interferon\/ribavirin therapy for chronic hepatitis C","volume":"30","author":"Omori-Mizuno","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2015.11.008_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jir.2014.0060","article-title":"Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon\/ribavirin","volume":"35","author":"Esmat","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jfma.2015.11.008_bib21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2014.08.004","article-title":"Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis","volume":"61","author":"Kitson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2015.11.008_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/gene.2009.65","article-title":"Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan","volume":"11","author":"Huang","year":"2010","journal-title":"Genes Immun"},{"key":"10.1016\/j.jfma.2015.11.008_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.11.008_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","article-title":"Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"20","author":"Fan","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2015.11.008_bib25","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.1302296","article-title":"Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-\u03b1","volume":"192","author":"Lange","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jfma.2015.11.008_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s005350300025","article-title":"Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis","volume":"38","author":"Hung","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jfma.2015.11.008_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0016-5085(00)70423-9","article-title":"Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis","volume":"118","author":"Springer","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2015.11.008_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gene.2004.05.014","article-title":"Genetics and biology of vitamin D receptor polymorphisms","volume":"338","author":"Uitterlinden","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.jfma.2015.11.008_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tranon.2014.05.001","article-title":"Significance of vitamin d receptor gene polymorphisms for risk of hepatocellular carcinoma in chronic hepatitis C","volume":"7","author":"Hung","year":"2014","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jfma.2015.11.008_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3851\/IMP2018","article-title":"The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon\/ribavirin-based therapy in chronic hepatitis C patients","volume":"17","author":"Baur","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jfma.2015.11.008_bib31","doi-asserted-by":"crossref","first-page":"e74764","DOI":"10.1371\/journal.pone.0074764","article-title":"Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon\/ribavirin therapy in chronic hepatitis C","volume":"8","author":"Garc\u00eda-Mart\u00edn","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jfma.2015.11.008_bib32","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.26002","article-title":"Spontaneous clearance of hepatitis C virus in an interleukin 28B favorable genotype highly prevalent area","volume":"57","author":"Hung","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.11.008_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00535-012-0669-x","article-title":"Host factors determining the efficacy of hepatitis C treatment","volume":"48","author":"Chuang","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jfma.2015.11.008_bib34","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.24201","article-title":"Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C\/T polymorphism in predicting antiviral response in chronic hepatitis C","volume":"53","author":"Bitetto","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.11.008_bib35","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00198-010-1383-2","article-title":"Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey","volume":"22","author":"Guti\u00e9rrez","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2015.11.008_bib36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3945\/ajcn.112.039974","article-title":"Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response","volume":"96","author":"Weintraub","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jfma.2015.11.008_bib37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(10)60588-0","article-title":"Common genetic determinants of vitamin D insufficiency: a genome-wide association study","volume":"376","author":"Wang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2015.11.008_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1009570","article-title":"Clinical practice. Vitamin D insufficiency","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664615003794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664615003794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T09:43:36Z","timestamp":1653903816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664615003794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0929664615003794"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2015.11.008","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2015.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier (Singapore) Pte Ltd.","name":"copyright","label":"Copyright"}]}}